Several studies identified WRN synthetic lethal vulnerability in cancers with microsatellite instability (218, 223, 224), suggesting specific WRN inhibitors hold great potential to target microsatellite instability tumors to enable a clear stratification path in the clinic. This evidence concerns the gene WRN and cancer.